Controlling Specialty Costs
We have identified an opportunity to save members millions of dollars in specialty medication costs – by managing specialty medication prior authorization functions within our Cooperative.
Now in our third year of the program, we are able to demonstrate significant savings, an elevated level of clinical quality, and enhanced customer service. Based on historical trends and market comparisons, we estimate that National CooperativeRx’s specialty medication prior authorization program contributed to approximately $25 million in cost avoidance across our Cooperative in 2024.
Read our blog to learn more about the results from the first two years of our specialty medication prior authorization program.
